Rite Aid Corp RAD
We take great care to ensure that the data presented and summarized in this overview for RITE AID CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding RAD
View all-
Ahrens Investment Partners LLC3.15KShares$5350.0% of portfolio
-
Cordasco Financial Network270Shares$450.0% of portfolio
-
Wipfli Financial Advisors Llc,210Shares$350.0% of portfolio
-
Highlander Capital Management, LLC Short Hills, NJ50Shares$80.0% of portfolio
-
Sargent Bickham Lagudis LLC15Shares$20.0% of portfolio
-
Bergan Kdv Wealth Management, LLC10Shares$10.0% of portfolio
-
Exane Derivatives3Shares$00.0% of portfolio
-
American Portfolios Advisors Holbrook, NY3Shares$00.0% of portfolio
-
Bartlett & Co. LLC1Shares$00.0% of portfolio
Latest Institutional Activity in RAD
Top Purchases
Top Sells
About RAD
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. In addition, this segment offers healthcare coaching and disease management services to health plans and employers. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. As of February 26, 2022, the company operated 2,450 retail pharmacy locations in 17 states. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.
Insider Transactions at RAD
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 27
2023
|
Justin L. Mennen EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,968
-3.52%
|
$4,968
$1.58 P/Share
|
Jul 27
2023
|
Matt Schroeder EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,349
-8.14%
|
$17,349
$1.58 P/Share
|
Jul 27
2023
|
Jessica Kazmaier EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,934
-7.17%
|
$6,934
$1.58 P/Share
|
Jul 07
2023
|
Jessica Kazmaier EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,239
-2.6%
|
$5,239
$1.64 P/Share
|
Jul 07
2023
|
Justin L. Mennen EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,178
-1.45%
|
$4,178
$1.64 P/Share
|
Jul 07
2023
|
Matt Schroeder EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,224
-3.18%
|
$14,224
$1.64 P/Share
|
Jul 07
2023
|
Steven Bixler Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
355
-4.66%
|
$355
$1.64 P/Share
|
Apr 25
2023
|
Jessica Kazmaier EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,953
+5.52%
|
-
|
Apr 25
2023
|
Justin L. Mennen EVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,547
+3.67%
|
-
|
Apr 25
2023
|
Matt Schroeder EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,416
+4.79%
|
-
|
Feb 03
2023
|
Andre Persaud EVP, Retail |
SELL
Payment of exercise price or tax liability
|
Direct |
2,076
-1.89%
|
$6,228
$3.76 P/Share
|
Aug 17
2022
|
Paul D Gilbert EVP, Secretary&General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,728
-2.44%
|
$27,280
$10.51 P/Share
|
Aug 12
2022
|
Heyward R Donigan President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,370
-3.96%
|
$411,070
$11.05 P/Share
|
Jul 27
2022
|
Louis Miramontes Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,505
+25.75%
|
-
|
Jul 27
2022
|
Bruce G. Bodaken Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,505
+23.9%
|
-
|
Jul 27
2022
|
Elizabeth Burr Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,505
+28.4%
|
-
|
Jul 27
2022
|
Heyward R Donigan President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
429,858
+31.32%
|
-
|
Jul 27
2022
|
Paul D Gilbert EVP, Secretary&General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
56,236
+33.45%
|
-
|
Jul 27
2022
|
Bari A Harlam Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,505
+32.57%
|
-
|
Jul 27
2022
|
Brian Hoover Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,429
+29.04%
|
-
|